The biopharmaceutical industry is undergoing rapid transformation due to the rising popularity of cell and gene therapy for various cancer conditions, some uncommon diseases, and degenerative conditions, as traditional drugs and biological products show limited success. The field is now moving to
The biotech industry in particular will experience high levels of uncertainty and changes in 2025. Emerging biotech companies are facing significant challenges due to new technologies, intense global competition, and changes in the market. Next year, 2025, may be tough for startups as they
The life sciences industry has come a long way since the last COVID-19 outbreak. Today, organizations are prioritizing efficiency, speed, and innovation. That’s why biopharma and biotech companies are increasingly broadening their investments in physical spaces. Campuses and facilities are being
The global brain-computer interface (BCI) market is expected to grow from USD $2.1 million in 2022 to USD $9.4 million by 2032, with a growth rate of 16.7% from 2023 to 2032. This exciting area of research and development can create a direct communication link between the human brain and devices
In an era when speed, accuracy, and efficiency are critical, the biopharma industry stands on the verge of a huge transformation. Artificial intelligence (AI) is moving beyond just a mere buzzword; it is fast becoming an important factor in how drugs are discovered, developed, and marketed. The
There is no question that obesity is one of the most common healthcare problems plaguing the modern world. According to the National Health and Nutrition Examination Survey (NHANES), 42.4% of Americans suffer from obesity, while 30.7% are on their way to becoming obese. Moreover, approximately 1 in
